2026 Elotuzumab single unit price analysis

Elotuzumab(Elotuzumab) is a targeted immunotherapy for the treatment of multiple myeloma (MM) in adults. It has been approved in the international market, but has not yet been officially launched in mainland China. Therefore, for domestic patients, the price and medical insurance coverage are not yet clear. The pricing of overseas original drugs is for reference. Each box of the European version of 300 mg is priced at about 15,000 yuan. However, this price is affected by exchange rate fluctuations and regional pricing policies, and there may be certain differences. Compared with some chemotherapy or conventional targeted drugs, the price of a single dose of evolizumab is relatively high. This is mainly due to its research and development costs as a monoclonal antibody drug, the complexity of the production process, and the special value of targeted immunotherapy in clinical practice.

In the international market, evolizumab is usually used in combination with lenalidomide (Lenalidomide) or pomalidomide and dexamethasone (Dexamethasone) to treat patients with multiple myeloma. This combined strategy improves patient outcomes while also increasing the total cost of treatment. Therefore, overseas guidelines and medical experts generally recommend rational evaluation of treatment options within an affordable range and, if necessary, the selection of clinical trials or patient assistance programs to reduce the burden of long-term medication.

There are currently no generic versions of evolizumab on the market. This means that patients must obtain original drugs through formal channels when purchasing overseas to ensure drug quality and safety. Overseas practice shows that the production and transportation of monoclonal antibody drugs require strict storage conditions, and uncertified channels have risks of unstable quality, which may affect efficacy and increase the incidence of adverse reactions. Therefore, when comparing prices and making medication decisions, we should not only pay attention to the single price, but also consider the comprehensive cost of treatment, length of treatment, and drug safety management.

Reference materials:https://www.drugs.com/mtm/elotuzumab.html